Breast cancer treatment breakthrough ‘will save lives’
International tests carried out on 1,500 women found that 75% of them treated with a new three-drug chemotherapy combination remained disease free after four-and-a-half years. This compares to 68% of women on the traditional treatment.
All of the women had early stage breast cancer. The study found a significant lower rate of relapse in women using the drug combination containing taxotere, adriamycin and cyclophosphamide (TAC).
